Viewing StudyNCT00400101



Ignite Creation Date: 2024-05-05 @ 5:10 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00400101
Status: TERMINATED
Last Update Posted: 2006-11-16
First Post: 2006-11-15

Brief Title: Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides
Sponsor: Swiss Tropical Public Health Institute
Organization: Swiss Tropical Public Health Institute

Conditions & Keywords Data

Conditions:
Name
Falciparum Malaria
Keywords:
Name View
immunogenicity View
Malaria View
Vaccine View
Plasmodium View
falciparum View
Phase I View
Peptide View
Virosome View
safety View